Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Simple Resolution 140
115th Congress(2017-2018)
A resolution supporting the designation of April 2017 as "Parkinson's Awareness Month".
Active
Active
Passed Senate on Apr 25, 2017
Overview
Text
Agreed to Senate 
Apr 25, 2017
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Agreed to Senate(Apr 25, 2017)
Apr 25, 2017
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. RES. 140 (Agreed-to-Senate)


115th CONGRESS
1st Session
S. RES. 140


Supporting the designation of April 2017 as “Parkinson’s Awareness Month”.

IN THE SENATE OF THE UNITED STATES

April 25, 2017

Mr. Isakson (for himself and Ms. Stabenow) submitted the following resolution; which was considered and agreed to

RESOLUTION

Supporting the designation of April 2017 as “Parkinson’s Awareness Month”.

    Whereas Parkinson’s disease is a chronic, progressive neurological disease and is the second most common neurodegenerative disease in the United States;

    Whereas there is inadequate data on the incidence and prevalence of Parkinson’s disease, but the disease affects an estimated 1,000,000 individuals in the United States and its prevalence is expected to more than double by 2040;

    Whereas, according to the Centers for Disease Control and Prevention, Parkinson’s disease is the 14th leading cause of death in the United States;

    Whereas every day Parkinson's disease greatly impacts millions of individuals in the United States who are caregivers, family members, and friends of individuals with Parkinson's disease;

    Whereas, although research suggests that the cause of Parkinson’s disease is a combination of genetic and environmental factors, the exact cause of the disease in most individuals is still unknown;

    Whereas, as of March 2017, there is no objective test or biomarker for diagnosing Parkinson’s disease;

    Whereas there is no known cure or drug to slow or halt the progression of Parkinson's disease, and available treatments are limited in their ability to address the medical needs of patients and remain effective over time;

    Whereas the symptoms of Parkinson’s disease vary from person to person and may include—

    (1) tremors;

    (2) slowness of movement and rigidity;

    (3) difficulty with balance and gait;

    (4) disturbances in speech and swallowing;

    (5) cognitive impairment and dementia;

    (6) mood disorders; and

    (7) a variety of other nonmotor symptoms;

    Whereas volunteers, researchers, caregivers, and medical professionals are working to improve the quality of life for individuals living with Parkinson's disease and their families; and

    Whereas increased research, education, and community support services are needed—

    (1) to find more effective treatments; and

    (2) to provide access to quality care for individuals living with Parkinson's disease: Now, therefore, be it

Resolved,

That the Senate—

(1) designates April 2017 as “Parkinson's Awareness Month”;

(2) supports the goals and ideals of Parkinson's Awareness Month;

(3) continues to support research to find better treatments and a cure for Parkinson's disease;

(4) recognizes the individuals living with Parkinson's disease who participate in vital clinical trials to advance the knowledge of the disease; and

(5) commends the dedication of organizations, volunteers, researchers, and millions of individuals across the United States working to improve the quality of life for individuals living with Parkinson's disease and their families.